Max Robotics — Global Service Robot Directory + US Certification

About

Inserm, France's premier biomedical research institution, has established itself as a remarkably multidisciplinary powerhouse at the intersection of medicine, robotics, and artificial intelligence. With deep roots in clinical and translational research, Inserm researchers have made landmark contributions spanning surgical robotics, human-robot interaction, neural prediction mechanisms, and regenerative medicine technologies that collectively command thousands of citations worldwide. The institution's most distinctive contributions to robotics and AI emerge from its clinical context. Pioneering work on cerebellar involvement in predicting sensory consequences of action — using robotic arm paradigms and PET neuroimaging — fundamentally advanced our understanding of motor control and predictive coding. Equally groundbreaking was Inserm's early exploration of in vivo bioprinting for computer- and robot-assisted medical intervention, establishing a vision for precision biological fabrication that continues to inspire the field. In surgical robotics, Inserm researchers have produced influential systematic reviews of tool detection and tracking, teleoperative latency effects, robotic prostatectomy outcomes, and ergonomic assessments of robotic versus standard laparoscopy — forming an essential evidence base for clinical adoption worldwide. Beyond the operating theater, Inserm has contributed meaningfully to social robotics, demonstrating how humanoid robots can leverage gaze cues in cooperative tasks, and to rehabilitation, with meta-analyses validating robotic gait training post-stroke. Work on gerontechnology addresses pressing societal challenges of aging independence, while unsupervised surgical gesture recognition advances automated training assessment. Prospective students and collaborators will find in Inserm a uniquely fertile environment where clinical urgency drives technological innovation, supported by world-class infrastructure, strong WHO partnerships, and an unmatched capacity to translate fundamental robotics and AI research into real-world patient impact.